Fairfax Financial Holdings’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,810
Closed -$416K 46
2017
Q3
$416K Hold
5,810
0.03% 41
2017
Q2
$394K Hold
5,810
0.03% 23
2017
Q1
$393K Hold
5,810
0.03% 25
2016
Q4
$359K Sell
5,810
-3,660
-39% -$216K 0.03% 26
2016
Q3
$512K Hold
9,470
0.05% 23
2016
Q2
$431K Hold
9,470
0.03% 24
2016
Q1
$466K Hold
9,470
0.03% 27
2015
Q4
$380K Buy
+9,470
New +$435K 0.03% 26
2015
Q3
Sell
-3,660
Closed -$291K 42
2015
Q2
$291K Hold
3,660
0.02% 41
2015
Q1
$301K Hold
3,660
0.02% 35
2014
Q4
$325K Buy
+3,660
New +$331K 0.02% 32

Other funds holding ENOV

Fairfax Financial Holdings's ENOV Position: Q4 2017 in Review

Fairfax Financial Holdings sold out of Enovis (ENOV) in Q4 2017, closing a stake of 5,810 shares — an estimated $416K sold.

Fairfax Financial Holdings first reported a position in ENOV in Q4 2014 and held it in 11 quarters. The position peaked at $512K in Q3 2016. 210 funds tracked by Wall St. Rank hold ENOV as of Q4 2017.

  • Fairfax Financial Holdings reported no remaining Enovis position as of Q4 2017 after selling out during the quarter.
  • Fairfax Financial Holdings sold 5,810 Enovis shares in Q4 2017, an estimated $416K.
  • Fairfax Financial Holdings first reported a position in Enovis in Q4 2014 and held it in 11 quarters.
  • Fairfax Financial Holdings's Enovis position peaked at $512K in Q3 2016.
  • 210 funds tracked by Wall St. Rank held Enovis as of Q4 2017.

Based on Fairfax Financial Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.